STOCK TITAN

scPharmaceuticals Inc. (SCPH) Revenue by Year

SCPH

scPharmaceuticals Inc. generated $36.3M in revenue in fiscal year 2024. This represents an increase of 167.3% from the prior fiscal year. Over the trailing 12 months, Q3 FY2024 through Q2 FY2025, the same line adds up to $50.0M in revenue. The table below carries 9 fiscal years, from 2016 to 2024, and the quarters scPharmaceuticals Inc. has filed alongside them.

FY2024 annual
Revenue $36.3M
YoY +167.3%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2025, ended Jun 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SCPH Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-K
Revenue$50.0M$36.3M+167.3%$13.6MN/AN/AN/AN/AN/AN/AN/A

TTM is the trailing twelve months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.

SCPH Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-Q
Revenue$16.0M+99.2%$11.8M+92.6%$12.2M+99.3%$10.0M+164.1%$8.1M+391.7%$6.1M+195.8%$6.1M$3.8M$1.6M$2.1MN/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More scPharmaceuticals Inc. financials

Frequently Asked Questions

What was scPharmaceuticals Inc.'s revenue in fiscal year 2024?

scPharmaceuticals Inc. generated $36.3M in revenue in fiscal year 2024.

How fast is scPharmaceuticals Inc.'s revenue growing?

scPharmaceuticals Inc. (SCPH) revenue rose by 167.3% year over year, from $13.6M to $36.3M in fiscal year 2024.

What is scPharmaceuticals Inc.'s revenue over the last twelve months?

scPharmaceuticals Inc. (SCPH) reported $50.0M in revenue over the trailing 12 months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.

scPharmaceuticals Inc. (SCPH) reported $16.0M in revenue in Q2 2025. This represents an increase of 99.2% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what scPharmaceuticals Inc. (SCPH) reported on that line in every period on record.